Levothyroxine in Euthyroid Peroxidase Antibody–Positive Women With Recurrent Pregnancy Loss
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Diabetes Endocrinol 2022 May 01;10(5)322-329, MM van Dijk, R Vissenberg, E Fliers, JAM van der Post, MP van der Hoorn, S de Weerd, WK Kuchenbecker, A Hoek, JM Sikkema, HR Verhoeve, KA Broeze, CH de Koning, W Verpoest, OB Christiansen, C Koks, JP de Bruin, DNM Papatsonis, H Torrance, M van Wely, PH Bisschop, M GoddijnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.